{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:35:51Z","timestamp":1785803751294,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypophosphatasia (HPP), a skeletal disease characterized by hypomineralization of bone and teeth, is caused by an <jats:italic>ALPL<\/jats:italic> gene mutation that leads to low activity of the tissue non-specific alkaline phosphatase enzyme. Although enzyme replacement therapy (ERT) was recently introduced for affected patients, no known studies have been reported regarding its dental effects related to permanent teeth and jaw bones. In the present study, we examined the dental effects of ERT in a case of childhood-type hypophosphatasia, including panoramic radiography findings used to estimate the dental age of permanent teeth and mandibular bone density. Furthermore, the effects of that therapy on the periodontal condition of the patient were evaluated by comparing periodontal pocket depth before and after initiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An 11-year-1-month-old boy was referred to our clinic for consultation regarding oral management. Two primary incisors had spontaneously exfoliated at 1\u00a0year 8\u00a0months old and he had been diagnosed with childhood-type HPP at the age of 2\u00a0years 2\u00a0months. Obvious symptoms were localized in the dental region at the time of diagnosis, though later extended to other parts of the body such as bone pain. ERT was started at 11\u00a0years 7\u00a0months of age, after which bone pain disappeared, and motor functions and activities of daily living improved. We estimated dental age based on tooth development stage. The age gap between chronological and dental ages was expanded before treatment, and then showed a constant decrease after ERT initiation and finally disappeared. The index for mandibular bone density (mandibular cortical width \/ length from mesial buccal cusp to apex of first molar) was increased after ERT initiation. Furthermore, the periodontal condition for all teeth except those exfoliated was stable after starting therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ERT resulted in improved tooth and mandibular bone mineralization, with notably good effects on teeth under formation. Acceleration of mineralization of roots associated with erupting teeth leads to stabilization of the periodontal condition. We concluded that ERT contributed to the improved dental condition seen in this patient.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-021-01673-2","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T13:02:27Z","timestamp":1624798947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-209X","authenticated-orcid":false,"given":"Rena","family":"Okawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kokomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"key":"1673_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015;75:229\u201339.","journal-title":"Bone"},{"issue":"4","key":"1673_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP. Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233\u201346.","journal-title":"Nat Rev Endocrinol"},{"key":"1673_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","volume":"93","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Wenkert D, Zhang F. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center. Bone. 2016;93:125\u201338.","journal-title":"Bone"},{"key":"1673_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.metabol.2017.08.013","volume":"82","author":"E Mornet","year":"2018","unstructured":"Mornet E. Hypophosphatasia. Metabolism. 2018;82:142\u201355.","journal-title":"Metabolism"},{"issue":"2","key":"1673_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0917-2394(12)70266-5","volume":"22","author":"R Okawa","year":"2012","unstructured":"Okawa R, Nakano K, Matsumoto M, Kawabata K, Ooshima T. Oral manifestations of patients with hypophosphatasia. Ped Dent J. 2012;22(2):155\u201362.","journal-title":"Ped Dent J"},{"key":"1673_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/ipd.12232","volume":"26","author":"A Bloch-Zupan","year":"2016","unstructured":"Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs\u2014a dental surgeon perspective. Int J Paediatr Dent. 2016;26:426\u201338.","journal-title":"Int J Paediatr Dent"},{"issue":"12","key":"1673_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.bdj.2018.441","volume":"224","author":"C Feeney","year":"2018","unstructured":"Feeney C, Stanford N, Lee S, Barry S. Hypophosphatasia and the importance of the general dental practitioner\u2014a case series and discussion of upcoming treatments. Br Dent J. 2018;224(12):937\u201343.","journal-title":"Br Dent J"},{"issue":"10","key":"1673_CR8","doi-asserted-by":"publisher","first-page":"e0222931","DOI":"10.1371\/journal.pone.0222931","volume":"14","author":"R Okawa","year":"2019","unstructured":"Okawa R, Kokomoto K, Kitaoka T, Kubota T, Watanabe A, Taketani T, et al. Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types. PLoS ONE. 2019;14(10):e0222931.","journal-title":"PLoS ONE"},{"key":"1673_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1297\/cpe.29.9","volume":"29","author":"T Michigami","year":"2020","unstructured":"Michigami T, Ohata Y, Fujiwara M, Mochizuki H, Adachi M, Kitaoka T, et al. Clinical practice guidelines for hypophosphatasia. Clin Pediatr Endocrinol. 2020;29:9\u201324.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"9","key":"1673_CR10","first-page":"e85971","volume":"16,1","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016;16,1(9):e85971.","journal-title":"JCI Insight."},{"issue":"4","key":"1673_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jbmr.3075","volume":"32","author":"MP Whyte","year":"2017","unstructured":"Whyte MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res. 2017;32(4):667\u201375.","journal-title":"J Bone Miner Res"},{"issue":"1\u20132","key":"1673_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2017.07.010","volume":"122","author":"PS Kishnani","year":"2017","unstructured":"Kishnani PS, Del Angel G, Zhou S, Rush ET. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1\u20132):4\u201317.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1673_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Simmons JH, Moseley S, Fujita K, Bishop N, Salmon N, et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019;7(2):93\u2013105.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1673_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","volume":"121","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019;121:149\u201362.","journal-title":"Bone"},{"issue":"3","key":"1673_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00431-015-2641-2","volume":"175","author":"Y Okazaki","year":"2016","unstructured":"Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth. Eur J Pediatr. 2016;175(3):433\u20137.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"1673_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cen.13343","volume":"87","author":"T Kitaoka","year":"2017","unstructured":"Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, et al. Safety and efficacy with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol. 2017;87(1):10\u20139.","journal-title":"Clin Endocrinol"},{"key":"1673_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pdj.2017.04.002","volume":"27","author":"R Okawa","year":"2017","unstructured":"Okawa R, Kokomoto K, Yamaura-Miyazaki N, Michigami T, Nakano K. Oral findings in patient with lethal hypophosphatasia with enzyme replacement therapy. Ped Dent J. 2017;27:153\u20136.","journal-title":"Ped Dent J"},{"issue":"5","key":"1673_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.17796\/1053-4625-44.5.9","volume":"44","author":"R Okawa","year":"2020","unstructured":"Okawa R, Matayoshi S, Kariya R, Ogaya Y, Nomura R, Nakano K. Effects of enzyme replacement therapy for primary teeth in a patient with infantile hypophosphatasia. J Clin Pediatr Dent. 2020;44(5):348\u201351.","journal-title":"J Clin Pediatr Dent"},{"issue":"3","key":"1673_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pdj.2017.08.005","volume":"27","author":"R Okawa","year":"2017","unstructured":"Okawa R, Miura J, Kokomoto K, Kubota T, Kitaoka T, Ozono K, et al. Early exfoliation of permanent tooth in patient with hypophosphatasia. Ped Dent J. 2017;27(3):173\u20138.","journal-title":"Ped Dent J"},{"key":"1673_CR20","first-page":"103","volume":"66","author":"K Haavikko","year":"1970","unstructured":"Haavikko K. The formation and the alveolar and clinical eruption of the permanent teeth. An orthopantomographic study. Suom Hammaslaak Toim. 1970;66:103\u201370.","journal-title":"Suom Hammaslaak Toim"},{"key":"1673_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-263X.1999.00145.x","volume":"9","author":"K Nakano","year":"1999","unstructured":"Nakano K, Matsuoka T, Takahashi A, Matsumura M, Sobue S, Ooshima T. Delayed development or congenital absence of a single first permanent molar in Japanese child patients. Int J Paed Dent. 1999;9:271\u20136.","journal-title":"Int J Paed Dent"},{"key":"1673_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jdsr.2009.05.001","volume":"15","author":"A Taguchi","year":"2009","unstructured":"Taguchi A. Panoramic radiographs for identifying individuals with undetected osteoporosis. Jpn Dent Sci Rev. 2009;15:109\u201320.","journal-title":"Jpn Dent Sci Rev"},{"issue":"1","key":"1673_CR23","first-page":"68","volume":"102","author":"E Klemetti","year":"1994","unstructured":"Klemetti E, Kolmakov S, Kr\u00f6ger H. Pantomography in assessment of the osteoporosis risk group. Scand Dent Res. 1994;102(1):68\u201372.","journal-title":"Scand Dent Res"},{"issue":"3 Suppl","key":"1673_CR24","doi-asserted-by":"publisher","first-page":"95S","DOI":"10.1177\/0022034514567334","volume":"94","author":"AC Apolin\u00e1rio","year":"2015","unstructured":"Apolin\u00e1rio AC, Figueiredo PT, Guimar\u00e3es AT, Acevedo AC, Castro LC, Paula AP, et al. Pamidronate affects the mandibular cortex of children with osteogenesis imperfecta. J Dent Res. 2015;94(3 Suppl):95S-102S.","journal-title":"J Dent Res"},{"issue":"4","key":"1673_CR25","doi-asserted-by":"publisher","first-page":"20150400","DOI":"10.1259\/dmfr.20150400","volume":"45","author":"AC Apolin\u00e1rio","year":"2016","unstructured":"Apolin\u00e1rio AC, Sindeaux R, de Souza Figueiredo PT, Guimar\u00e3es AT, Acevedo AC, Castro LC, et al. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment. Dentomaxillofac Radiol. 2016;45(4):20150400.","journal-title":"Dentomaxillofac Radiol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-021-01673-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T13:02:57Z","timestamp":1624798977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-021-01673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1186\/s12903-021-01673-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,27]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Osaka University of Graduate school of Dentistry (protocol code H29-E15-1 and date of approval Sep. 12. 2017). Informed consent to participate from a parent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from a parent and the patient for publication of this case report and the accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}